Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256163876> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W4256163876 endingPage "400" @default.
- W4256163876 startingPage "397" @default.
- W4256163876 abstract "We report on a 24-year-old woman with juvenile idiopathic arthritis (JIA) who developed subacute thyroiditis (SAT) while being treated with etanercept. She had suffered from JIA for 12 years, and her arthritis proved refractory to treatment with ibuprofen, prednisolone, and methotrexate. For the past 5 years, the patient had been treated successfully with etanercept at 25 mg/week. The patient more recently complained of high fever and lassitude, and presented with anterior neck swelling and tenderness. Palpation of the thyroid gland revealed it to be warm, erythematous, tender, and diffusely swollen. Laboratory tests revealed an increased erythrocyte sedimentation rate and C-reactive protein level. Thyroid function tests revealed decreased levels of thyrotropin-stimulating hormone, increased levels of free triiodothyronine, free thyroxine, and thyroglobulin, and an absence of thyroid autoantibodies. Sonography showed a diffusely reduced predominantly hypoechoic thyroid gland. Unenhanced computed tomography of the neck showed a homogeneously and mildly reduced thyroid gland. Serum titers of several viruses were not significant and so were considered unlikely to be the pathogens. On the basis of these presented findings, we diagnosed SAT, and etanercept therapy was withdrawn. The patient was treated with antibiotics and an increased prednisolone dose was initiated. She became symptom free and showed improved laboratory test results within 2 weeks, and was euthyroid by 3 months. Three months later, the patient developed hypothyroidism, although 6 months further on, the patient was asymptomatic on prednisolone, methotrexate, and levothyroxine therapy. In conclusion, whether SAT is a specific adverse event in this case in response to etanercept remains unclear. Nevertheless, the possibility of SAT should be considered in such patients on etanercept treatment." @default.
- W4256163876 created "2022-05-12" @default.
- W4256163876 creator A5023124488 @default.
- W4256163876 date "2013-03-01" @default.
- W4256163876 modified "2023-09-27" @default.
- W4256163876 title "Subacute thyroiditis in a patient with juvenile idiopathic arthritis undergoing etanercept treatment: a case report and review of the literature" @default.
- W4256163876 cites W1964215887 @default.
- W4256163876 cites W1980697960 @default.
- W4256163876 cites W1982641042 @default.
- W4256163876 cites W1993566067 @default.
- W4256163876 cites W2015587030 @default.
- W4256163876 cites W2056441943 @default.
- W4256163876 cites W2057298878 @default.
- W4256163876 cites W2084372511 @default.
- W4256163876 cites W2152245204 @default.
- W4256163876 doi "https://doi.org/10.3109/s10165-012-0670-5" @default.
- W4256163876 hasPublicationYear "2013" @default.
- W4256163876 type Work @default.
- W4256163876 citedByCount "10" @default.
- W4256163876 countsByYear W42561638762014 @default.
- W4256163876 countsByYear W42561638762015 @default.
- W4256163876 countsByYear W42561638762017 @default.
- W4256163876 countsByYear W42561638762018 @default.
- W4256163876 countsByYear W42561638762020 @default.
- W4256163876 countsByYear W42561638762021 @default.
- W4256163876 countsByYear W42561638762022 @default.
- W4256163876 countsByYear W42561638762023 @default.
- W4256163876 crossrefType "journal-article" @default.
- W4256163876 hasAuthorship W4256163876A5023124488 @default.
- W4256163876 hasConcept C126322002 @default.
- W4256163876 hasConcept C141071460 @default.
- W4256163876 hasConcept C2775883008 @default.
- W4256163876 hasConcept C2776216339 @default.
- W4256163876 hasConcept C2776715498 @default.
- W4256163876 hasConcept C2777077863 @default.
- W4256163876 hasConcept C2777195454 @default.
- W4256163876 hasConcept C2777226972 @default.
- W4256163876 hasConcept C2777575956 @default.
- W4256163876 hasConcept C2778143017 @default.
- W4256163876 hasConcept C2778696486 @default.
- W4256163876 hasConcept C2778840127 @default.
- W4256163876 hasConcept C526584372 @default.
- W4256163876 hasConcept C71924100 @default.
- W4256163876 hasConcept C90924648 @default.
- W4256163876 hasConceptScore W4256163876C126322002 @default.
- W4256163876 hasConceptScore W4256163876C141071460 @default.
- W4256163876 hasConceptScore W4256163876C2775883008 @default.
- W4256163876 hasConceptScore W4256163876C2776216339 @default.
- W4256163876 hasConceptScore W4256163876C2776715498 @default.
- W4256163876 hasConceptScore W4256163876C2777077863 @default.
- W4256163876 hasConceptScore W4256163876C2777195454 @default.
- W4256163876 hasConceptScore W4256163876C2777226972 @default.
- W4256163876 hasConceptScore W4256163876C2777575956 @default.
- W4256163876 hasConceptScore W4256163876C2778143017 @default.
- W4256163876 hasConceptScore W4256163876C2778696486 @default.
- W4256163876 hasConceptScore W4256163876C2778840127 @default.
- W4256163876 hasConceptScore W4256163876C526584372 @default.
- W4256163876 hasConceptScore W4256163876C71924100 @default.
- W4256163876 hasConceptScore W4256163876C90924648 @default.
- W4256163876 hasIssue "2" @default.
- W4256163876 hasLocation W42561638761 @default.
- W4256163876 hasOpenAccess W4256163876 @default.
- W4256163876 hasPrimaryLocation W42561638761 @default.
- W4256163876 hasRelatedWork W18478890 @default.
- W4256163876 hasRelatedWork W2009789922 @default.
- W4256163876 hasRelatedWork W2290951134 @default.
- W4256163876 hasRelatedWork W2325709188 @default.
- W4256163876 hasRelatedWork W2808213489 @default.
- W4256163876 hasRelatedWork W2981371894 @default.
- W4256163876 hasRelatedWork W3021079246 @default.
- W4256163876 hasRelatedWork W3109267171 @default.
- W4256163876 hasRelatedWork W4312237781 @default.
- W4256163876 hasRelatedWork W2003951433 @default.
- W4256163876 hasVolume "23" @default.
- W4256163876 isParatext "false" @default.
- W4256163876 isRetracted "false" @default.
- W4256163876 workType "article" @default.